A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding

Clinical Therapeutics

Volumn 31, Issue 9, 2009, Pages 2038-2047

  Hsiao, Fei Yuan ^a,b   Tsai, Yi Wen ^b,c   Huang, Weng Foung ^b   Wen, Yu Wen ^c   Chen, Pei Fen ^c   Chang, Po Yin ^b   Kuo, Ken N ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

aspirin; clopidogrel; gastrointestinal bleeding or perforation; hospitalization; peptic ulcer; PPIs; proton pump inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PROTON PUMP INHIBITOR;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; DOSE RESPONSE; DRUG COST; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENDER; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; ASPIRIN; CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; DRUG COSTS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; PEPTIC ULCER; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; SECONDARY PREVENTION; TAIWAN; TICLOPIDINE;

EID: 72249105864     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.09.005     Document Type: Article

References (18)

1. Tran H., and Anand S.S. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA. 292 (2004) 1867-1874
2. Patrono C., García Rodríguez L.A., Landolfi R., and Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med. 353 (2005) 2373-2383
3. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [published correction appears in BMJ. 2002;324:141]. BMJ. 324 (2002) 71-86
4. Derry S., and Loke Y.K. Risk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysis. BMJ. 321 (2000) 1183-1187
5. Laine L. Review article: Gastrointestinal bleeding with low-dose aspirin-what's the risk?. Aliment Pharmacol Ther. 24 (2006) 897-908
6. McQuaid K.R., and Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 119 (2006) 624-638
7. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
8. Ng F.H., Wong S.Y., Chang C.M., et al. High incidence of clopidogrelassociated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther. 18 (2003) 443-449
9. Lai K.C., Lam S.K., Chu K.M., et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med. 346 (2002) 2033-2038
10. Fraker Jr. T.D., Fihn S.D., Gibbons R.J., et al., 2002 Chronic Stable Angina Writing Committee, American College of Cardiology; American Heart Association. 2007 Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina [published correction appears in J Am Coll Cardiol. 2007;50:e1]. J Am Coll Cardiol. 50 (2007) 2264-2274
11. Harrington R.A., Becker R.C., Ezekowitz M., et al. Antithrombotic therapy for coronary artery disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 126 Suppl 3 (2004) 513S-548S
12. Anderson J.L., Adams C.D., Antman E.M., et al., American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction), American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/ Non ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine [published correction appears in Circulation. 2008;117: e180]. Circulation 116 (2007) e148-e304
13. Ng F.H., Wong B.C., Wong S.Y., et al. Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re-bleeding risk-a single-blind, randomized controlled study. Aliment Pharmacol Ther. 19 (2004) 359-365
14. WHO Collaborating Centre for Drug Statistics Methodology. The ATC and DDD system. http://www.whocc.no/atcddd/ Accessed September 29, 2008
15. Chan F.K., Ching J.Y., Hung L.C., et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 352 (2005) 238-244
16. Lai K.C., Chu K.M., Hui W.M., et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol. 4 (2006) 860-865
17. Fork F.T., Lafolie P., Tóth E., and Lindgärde F. Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study. Scand J Gastroenterol. 35 (2000) 464-469
18. Gilard M., Arnaud B., Cornily J.C., et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: The randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol. 51 (2008) 256-260